Weekly Intelligence · 3 articles
Vet Industry Intel: Jun 28 – Jul 4, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Regulatory & Policy (3)
Regulatory & Policy
Jul 3, 2026 [10/10] BioPharma APAC
Anivive Wins Full U.S. FDA Approval for Laverdia, First At-Home Oral Treatment for Canine Lymphoma
Anivive received full U.S. FDA approval for Laverdia, an at-home oral treatment for canine lymphoma.
Anivive · FDA | CA
Jun 29, 2026 [9/10] Vet Candy
FDA Grants Full Approval to Laverdia — The First Oral, At-Home Treatment for Canine Lymphoma
The U.S. Food and Drug Administration granted full approval to Laverdia, the first oral, at-home treatment for canine lymphoma.
FDA · Vet Candy
Jul 1, 2026 [7/10] PBS
As veterinary costs climb, private equity ownership of clinics draws scrutiny
Private equity ownership of veterinary clinics is facing increased regulatory and public scrutiny as pet healthcare costs continue to rise.